Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer

Oncology (Williston Park). 2021 Apr 19;35(4):166. doi: 10.46883/ONC.2021.3504.0166.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Disease Progression
  • Humans
  • Male
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / pathology*
  • Research Design

Substances

  • Antineoplastic Agents